## DVN: Devon Energy Corporation - XLE: Energy

### Executive Summary

No thesis match: MRS_20 -1.4% below STRENGTH zone (4.0-10.0%); PEG 14.90 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($34.24)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 7
- **Sentiment:** Bullish (Bullish: 2, Bearish: 0)

**1. Devon Energy Corporation $DVN Shares Sold by Voya Investment Management LLC**
- Source: MarketBeat | 20251220T140743 | Neutral | Relevance: 100%
- Voya Investment Management LLC reduced its stake in Devon Energy Corporation by 2.8% in the third quarter, selling 55,668 shares and retaining 1,914,632 shares valued at approximately $67.13 million. Despite this reduction, analysts maintain a "Moderate Buy" rating for DVN with a consensus target price of $44.86, supported by recent upgrades from firms like JPMorgan. Devon Energy reported strong quarterly earnings, beating estimates, and announced a quarterly dividend of $0.24 per share.

**2. Perpetual Ltd Invests $1.07 Million in Devon Energy Corporation $DVN**
- Source: MarketBeat | 20251222T110848 | Somewhat-Bullish | Relevance: 100%
- Perpetual Ltd has acquired a new stake of 30,451 shares, worth approximately $1.07 million, in Devon Energy Corporation during the third quarter. This move aligns with a broader trend of increased institutional ownership, with major funds like AQR and Ameriprise significantly boosting their positions. Devon Energy also announced a quarterly dividend of $0.24, reinforcing its cash-return strategy, and holds a "Moderate Buy" consensus rating from analysts, despite mixed price target adjustments.

**3. 4 Cheap Stock Picks We Still Like for 2026**
- Source: Morningstar | 20251222T150220 | Bullish | Relevance: 81%
- Morningstar analysts David Sekera and Susan Dziubinski review their 2025 stock picks, discussing both successes and failures, while also highlighting four undervalued stocks they continue to recommend for 2026: Biogen (BIIB), Microsoft (MSFT), LPL Financial (LPLA), and Devon Energy (DVN). They emphasize Morningstar's long-term investing philosophy and provide insights into their methodologies for buying and selling stocks.

**4. Coterra Energy (CTRA) Receives a Buy from Piper Sandler**
- Source: The Globe and Mail | 20251220T120758 | Bullish | Relevance: 64%
- Piper Sandler analyst Mark Lear has maintained a Buy rating on Coterra Energy (CTRA) with a price target of $37.00. This aligns with a general Strong Buy consensus among analysts for CTRA, with an average price target of $32.93. The company recently reported strong quarterly revenues of $1.82 billion and a net profit of $322 million.

**5. Coterra Energy (CTRA) Receives a Buy from Piper Sandler**
- Source: The Globe and Mail | 20251220T140739 | Somewhat-Bullish | Relevance: 64%
- Piper Sandler analyst Mark Lear maintained a Buy rating on Coterra Energy (CTRA) with a price target of $37.00. This rating is based on the company's latest earnings report, showing solid quarterly revenue and net profit growth. The general Street consensus on Coterra Energy is a Strong Buy with an average price target of $32.93.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 4, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-17 | Citigroup | $44 | $43 | +2% |
| 2025-12-12 | UBS | $46 | $40 | +15% |
| 2025-12-12 | Mizuho | $43 | $40 | +8% |
| 2025-12-11 | Morgan Stanley | $48 | $47 | +2% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-17 | Citigroup | main | Buy |
| 2025-12-12 | UBS | up | Buy |
| 2025-12-12 | Mizuho | main | Outperform |
| 2025-12-11 | Morgan Stanley | main | Overweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **MIXED** |
| Buys | 1 ($0.00M) |
| Sells | 1 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 41.4% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 3 |

**Top Holders:**
- Vanguard Group Inc: 13.0% (-0.2%)
- Blackrock Inc.: 9.6% (+4.5%)
- State Street Corpora: 5.6% (-4.9%)
- Geode Capital Manage: 3.0% (+2.1%)
- Victory Capital Mana: 1.9% (+5.0%)

### Key Risks

1. Valuation stretched: PEG 14.9x requires aggressive growth execution.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Analyst target momentum: 4 raises (avg +7%) could attract flows.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 14.90 signals overvaluation risk, limited margin of safety. Forward P/E 8.7x stretched relative to 3% growth. Quality metrics strong (margin 16%). Revenue declining -10% YoY, concerning. Analyst sentiment positive (4 raises, avg +7%). Institutional flow bullish (5 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $23.1B |
| Beta | 0.67 |
| 52W Range | $25.89 - $38.88 |
| Short Interest | 3.0% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 14.90 |
| Forward P/E | 8.7 |
| Current P/E | 9.0 |
| YoY Growth | 2.9% |
| EPS Direction | STABLE |

### Technicals

MRS_20 strengthening from -3.8% to -1.4% (+2.4% in 5 days), confirming momentum buildup. Below STRENGTH zone by 5.4pp (needs >4.0% for momentum thesis). Long-term uptrend intact (above SMA200 at 1.08x) but short-term weakness (below SMA20). RSI neutral at 51. OFD pattern: +DUL (Resistance).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -1.37% (CS: 31) | Neutral |
| RSI_14 | 51.4 | Neutral |
| MACD Histogram | -0.28 | Bearish |
| vs SMA20 | 0.987x | Below |
| vs SMA50 | 1.046x | Above |
| vs SMA200 | 1.080x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $36.42
- **Stop Loss:** $34.24 (6.0% risk)
- **Target:** $38.60 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 275
- **Position Value:** $10,015.50
- **Portfolio %:** 10.02%
- **Risk Dollars:** $600.00
- **Risk Per Trade:** 0.60%
- **Modifiers:** L1 120% | L2 50% | Combined 0.60x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | AVOID (Zone C) | 0.50x |

*NORMAL regime with improving risk appetite. VIX decline to 52-week lows and moderate breadth recovery suggest calming conditions, though narrow participation indicates selectivity remains key. Positive earnings momentum and AI adoption themes provide fundamental support for quality growth names.*

### Earnings

**Next:** 2026-02-17 (Est: $0.86)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.94 | $1.04 | +10.6% |
| 2025Q2 | $0.86 | $0.84 | -2.8% |
| 2025Q1 | $1.23 | $1.21 | -1.5% |
| 2024Q4 | $1.00 | $1.16 | +15.7% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*